Close Menu

Bitesize Bio's Vicki Ronaldson this week says that "despite the temptation to play down past academic pursuits amongst more corporate peers, a look at the top level management, or even the board, of any global life science or technology company will reveal a high percentage of PhDs, all of whom started out at the bench." But, she says, transitioning from academic research to the corporate world can be tough.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump might not approve the stricter standards the US Food and Drug Administration is developing for authorizing a SARS-CoV-2 vaccine, according to Politico.

Wired reports that Oxitec has now developed a genetically modified fall armyworm.

A large genetic study finds SARS-CoV-2 viruses with a certain variant are spreading more than others, according to the Washington Post.

In Nature this week: sister-chromatid-sensitive chromosome conformation capture approach, and more.